Paper89282
Evidence for raised K-cell levels in type-I diabetes.
Pozzilli P and 4 others. Lancet, 1979. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Evidence for raised K-cell levels in type-I diabetes. Papers, record 89282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/89282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Diabetes Mellitus | Major topic |
| Killer Cells, Natural | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Animals | |
| Child | |
| Diabetes Mellitus, Type 1 | |
| Erythrocytes | |
| Female | |
| Graves Disease | |
| Humans | |
| Islets of Langerhans | |
| Leukocyte Count | |
| Male | |
| Middle Aged | |
| Myxedema | |
| Organ Specificity | |
| Rosette Formation | |
| Sheep |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7445912 | The importance of measuring Fc+ (killer) cells in insulin-dependent (type 1) diabetes. | Acta Diabetol Lat | 1980 | https://conductscience.org/library/papers/7445912 | PubMed |
| 7331674 | Antibody-dependent and natural killer cytotoxicity in type 1 diabetes. | Acta Diabetol Lat | 1981 | https://conductscience.org/library/papers/7331674 | PubMed |
| 7202884 | Increased killer cell activity in insulin dependent (type 1) diabetes mellitus. | Diabetologia | 1981 | https://conductscience.org/library/papers/7202884 | PubMed |
| 7108149 | Inhibition of killer cell cytotoxicity induced by carbimazole in vitro. | J Endocrinol Invest | 1982 | https://conductscience.org/library/papers/7108149 | PubMed |
| 7009284 | Lymphocyte subpopulations in insulin-dependent diabetics with and without serum islet-cell autoantibodies. | Diabetologia | 1981 | https://conductscience.org/library/papers/7009284 | PubMed |
| 6998823 | Circulating immune complexes in diabetes. | Diabetologia | 1980 | https://conductscience.org/library/papers/6998823 | PubMed |
| 6983808 | An investigation into cytotoxic mechanisms in type I diabetes mellitus. | Acta Diabetol Lat | 1982 | https://conductscience.org/library/papers/6983808 | PubMed |
| 6758457 | Cell-mediated immunity and immune complexes in the pathogenesis of type 1 (insulin-dependent) diabetes. | Acta Diabetol Lat | 1982 | https://conductscience.org/library/papers/6758457 | PubMed |
| 6751634 | Histology of the islets of Langerhans following administration of human lymphocytes into athymic mice. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6751634 | PubMed |
| 6553509 | Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. II. In vitro and in vivo treatment using effector cells from normal and X-irradiated humans. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6553509 | PubMed |
| 6449332 | Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6449332 | PubMed |
| 6376230 | Beta-cell damage in diabetic insulitis: are we approaching a solution? | Diabetologia | 1984 | https://conductscience.org/library/papers/6376230 | PubMed |
| 6368298 | Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cells. | Diabetologia | 1984 | https://conductscience.org/library/papers/6368298 | PubMed |
| 6363509 | Immunology in the early stages of type I diabetes. | J Endocrinol Invest | 1983 | https://conductscience.org/library/papers/6363509 | PubMed |
| 6357917 | Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models. | Diabetologia | 1983 | https://conductscience.org/library/papers/6357917 | PubMed |
| 6341142 | Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes. | Diabetologia | 1983 | https://conductscience.org/library/papers/6341142 | PubMed |
| 6332754 | Prospective study of lymphocyte subsets in subjects genetically susceptible to type 1 (insulin-dependent) diabetes. | Diabetologia | 1984 | https://conductscience.org/library/papers/6332754 | PubMed |
| 6298043 | Virus-induced diabetes mellitus in mice and the thymus-dependent immune system. | Diabetologia | 1983 | https://conductscience.org/library/papers/6298043 | PubMed |
| 6237011 | Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. | Diabetologia | 1984 | https://conductscience.org/library/papers/6237011 | PubMed |
| 6227512 | T lymphocyte subsets in patients with newly diagnosed type 1 (insulin-dependent) diabetes: a prospective study. | Diabetologia | 1983 | https://conductscience.org/library/papers/6227512 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/89282
GET https://conductscience.org/api/papers/v1/89282/cited_by?page=2